Allan Lawrie, Ph.D.

Professor of Translational Cardiopulmonary Science at University of Sheffield Medical School

Allan Lawrie is a Professor of Translational Cardiopulmonary Science and British Heart Foundation Senior Basic Science Research Fellow in the Department of Infection, Immunity & Cardiovascular Disease at the University of Sheffield. Allan’s research has focused on identifying a key role for osteoprotegerin/TRAIL pathway in the pathogenesis of PAH. Supported by Fellowships and grants from the MRC and BHF he has recently developed a novel human therapeutic antibody targeting this pathway. Allan also works closely with clinical colleagues locally, nationally and internationally to identify biomarkers and utilise multi-omic approaches for molecular phenotyping, identifying novel disease mechanisms and drug targets.